Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raffaele Ornello

Showing results (151-160 of 183) with videos related to

Pageof 19
Sort By:
Cephalalgia : an International Journal of Headache|February 13, 2026
Levels of migraine controls following International Headache Society (IHS) recommendations with eptinezumab: Effectiveness and tolerability in a 24-week, prospective multicenter study (the TACHIS study)Luigi Francesco Iannone, Elisa Maria Piella, Danilo Antonio Montisano, et al.
Cephalalgia : an International Journal of Headache|August 12, 2024
International Headache Society global practice recommendations for the acute pharmacological treatment of migraineFrancesca Puledda, Simona Sacco, Hans-Christoph Diener, et al.
Stroke|March 23, 2023
Divergence Between Clinical Trial Evidence and Actual Practice in Use of Dual Antiplatelet Therapy After Transient Ischemic Attack and Minor StrokeEleonora De Matteis, Federico De Santis, Raffaele Ornello, et al.
Neurology|July 6, 2023
Incidence and Long-term Functional Outcome of Neurologic Disorders in Hospitalized Patients With COVID-19 Infected With Pre-Omicron VariantsSimone Beretta, Viviana Cristillo, Giorgia Camera, et al.
Journal of Neurology|October 23, 2025
Intravenous thrombolysis in patients with acute ischaemic stroke and active cancer (the ITACA-stroke study)Virginia Cancelloni, Giovanni Merlino, Gianluca Costamagna, et al.
Cephalalgia : an International Journal of Headache|April 25, 2025
Evidence-based guidelines for the pharmacological treatment of migraine, summary versionRaffaele Ornello, Valeria Caponnetto, Fayyaz Ahmed, et al.
Cephalalgia : an International Journal of Headache|April 25, 2025
Evidence-based guidelines for the pharmacological treatment of migraineRaffaele Ornello, Valeria Caponnetto, Fayyaz Ahmed, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 22, 2024
Redefining migraine prevention: early treatment with anti-CGRP monoclonal antibodies enhances response in the real worldEdoardo Caronna, Victor José Gallardo, Gabriella Egeo, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|November 18, 2024
Real-world comparison of dual versus single antiplatelet treatment in patients with non-cardioembolic mild-to-moderate ischemic stroke: A propensity matched analysisMatteo Foschi, Raffaele Ornello, Lucio D'Anna, et al.
European Journal of Neurology|April 23, 2025
Real-World Dual Antiplatelet Therapy Use Exceeds Randomized Trials Boundaries With Possible Safety Issues in Patients With Large Artery Atherosclerosis-Insights From the READAPT StudyEleonora De Matteis, Federico De Santis, Matteo Foschi, et al.
Pageof 19

Showing results (151-160 of 183) with videos related to

Sort By:
Pageof 19
Cephalalgia : an International Journal of Headache|February 13, 2026
Levels of migraine controls following International Headache Society (IHS) recommendations with eptinezumab: Effectiveness and tolerability in a 24-week, prospective multicenter study (the TACHIS study)Luigi Francesco Iannone, Elisa Maria Piella, Danilo Antonio Montisano, et al.
Cephalalgia : an International Journal of Headache|August 12, 2024
International Headache Society global practice recommendations for the acute pharmacological treatment of migraineFrancesca Puledda, Simona Sacco, Hans-Christoph Diener, et al.
Stroke|March 23, 2023
Divergence Between Clinical Trial Evidence and Actual Practice in Use of Dual Antiplatelet Therapy After Transient Ischemic Attack and Minor StrokeEleonora De Matteis, Federico De Santis, Raffaele Ornello, et al.
Neurology|July 6, 2023
Incidence and Long-term Functional Outcome of Neurologic Disorders in Hospitalized Patients With COVID-19 Infected With Pre-Omicron VariantsSimone Beretta, Viviana Cristillo, Giorgia Camera, et al.
Journal of Neurology|October 23, 2025
Intravenous thrombolysis in patients with acute ischaemic stroke and active cancer (the ITACA-stroke study)Virginia Cancelloni, Giovanni Merlino, Gianluca Costamagna, et al.
Cephalalgia : an International Journal of Headache|April 25, 2025
Evidence-based guidelines for the pharmacological treatment of migraine, summary versionRaffaele Ornello, Valeria Caponnetto, Fayyaz Ahmed, et al.
Cephalalgia : an International Journal of Headache|April 25, 2025
Evidence-based guidelines for the pharmacological treatment of migraineRaffaele Ornello, Valeria Caponnetto, Fayyaz Ahmed, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 22, 2024
Redefining migraine prevention: early treatment with anti-CGRP monoclonal antibodies enhances response in the real worldEdoardo Caronna, Victor José Gallardo, Gabriella Egeo, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|November 18, 2024
Real-world comparison of dual versus single antiplatelet treatment in patients with non-cardioembolic mild-to-moderate ischemic stroke: A propensity matched analysisMatteo Foschi, Raffaele Ornello, Lucio D'Anna, et al.
European Journal of Neurology|April 23, 2025
Real-World Dual Antiplatelet Therapy Use Exceeds Randomized Trials Boundaries With Possible Safety Issues in Patients With Large Artery Atherosclerosis-Insights From the READAPT StudyEleonora De Matteis, Federico De Santis, Matteo Foschi, et al.
Pageof 19